CMS Offers “Quickest Fix” To “Authorized” Generics, CEO Coury Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Medicare & Medicaid Services could provide the "quickest fix" for the generic industry's complaints about "authorized" generics, Mylan CEO Robert Coury said Feb. 3
You may also be interested in...
CMS Seeks List Of "Authorized" Generics For Use In "Best Price" Reporting, GPhA Says
The Generic Pharmaceutical Association anticipates the National Governors Association's updated Medicaid recommendations will endorse the inclusion of authorized generics in Medicaid "best price" reporting. CMS has indicated it will consider adding authorized generics to its calculations.
CMS Seeks List Of "Authorized" Generics For Use In "Best Price" Reporting, GPhA Says
The Generic Pharmaceutical Association anticipates the National Governors Association's updated Medicaid recommendations will endorse the inclusion of authorized generics in Medicaid "best price" reporting. CMS has indicated it will consider adding authorized generics to its calculations.
Cancer Drug “Quality Care” Demo Cushioning Reimbursement Change – ASCO
The Centers for Medicare & Medicaid Services' "quality care" demonstration project has taken pressure off oncologists facing lower reimbursement for Part B drugs, American Society of Clinical Oncology President David Johnson said Feb. 15